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Cardiac surgery is an effective, evidence-based clinical practice built on decades of 1 
research spanning from basic science to rigorous large animal studies and randomized 2 
controlled trials (RCTs) in patients. This translational approach has benefited patients 3 
enormously1. More recently, we are witnessing a surge of different research methods from 4 
bench-based simulation to overnight observational studies from registries and meta-5 
analysis that are raising questions and debates2. Concomitantly, in the era of innovation, 6 
we witness a crisis in research reproducibility3, limited reporting of registered RCTs4 and 7 
a call to re-surface rigorous large animal research5. One is left wondering if these are signs 8 
of a perfect storm. At these new times, the typical cardiac surgeon looks like a passive 9 
passenger on the boat of innovation, struggling to keep the rudder straight while sailing 10 
across the troubled waters of intellectual property, commercialization, conflict of interests, 11 
harm6 lack of evidence7, visibility, patient interest and evidence-based medicine. Who is 12 
who in this storm? Paulsen and colleagues8 have reported a bench-based model using a 3D-13 
printed heart simulator designed to test the long-term efficacy of two routinely used aortic 14 
conduits for valve sparing procedures. This is despite thousands of patients have already 15 
received these two conduits. The novelty of this report is that it tries to address an important 16 
clinical question on the long-term durability of the conduits using a bench-based simulator. 17 
The simulator is ingenious, modelling physiological waveforms and mechanical activities 18 
of the heart. Porcine aortic root/valves were sutured in the two conduits followed by 19 
implanting silicone tubes as mock coronary buttons. A long shot. At first look, few 20 
conflicting questions come to mind: is this simulator reliable? Can it really predict long-21 
term durability by running for few hours? Where is the rigorous confirmatory trial in large 22 
animals? Yet, we must respect this methodological approach as modern computational 23 
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modelling has been shown to be effective in predicting health outcome9. Based on the 24 
evidence arising from this simulation, the authors conclude that while the Valsalva Graft 25 
accurately reflect the aortic root geometry longitudinally, its radial displacement of the 26 
valve commissures triggers abnormal forces on the leaflets affecting their long-term 27 
durability. A strong conclusion, with not a single patient operated and not a drop of blood 28 
lost! With the only variable in this simulator being the type of conduit used, it might be 29 
that the highlighted difference is genuine. Who knows? In a traditional translational 30 
research pathway, this would trigger an immediate need for in-vivo validation in a relevant 31 
large animal model. However, the simulation has several limitations. The whole system 32 
looks too artificial as opposed to a typical in-vivo model. The lack of vascular elasticity in 33 
the system is an issue. Sub-optimal surgical expertise and/or mismatch between variable 34 
sizes of porcine valve used and the fixed diameter of the conduits selected might have 35 
affected the radial displacement of the leaflets. Finally, the simulation was conducted with 36 
normal saline solution and not with blood, using a fluid with different viscosity, hence 37 
affecting dynamics. These are the practical immediate criticisms that we can raise. 38 
Translational large animal models with advanced longitudinal in-vivo imaging would 39 
provide confirmatory knowledge of the pathophysiological, mechanistic and dynamic 40 
issues associated by this study with the Valsalva Graft surgical procedure. This, in turn, 41 
would have more robust implications on the clinical scenario, possibly warranting a call 42 
for a comparative RCT? The study by Paulsen and colleagues8 also highlights that 43 
undertaking isolated bench-based simulation, no matter how good it can be, does not help 44 
much in moving the field forward. This is because real translation occurs across a pipeline 45 
in which bench simulation represents only the first step. This illustrates the key learning 46 
point that bench-based modelling needs to go hand-to-hand with advanced in-vivo 47 
preclinical validation in relevant models10, to facilitate translation to bedside. Translating 48 
valuable basic science into patients requires time, funding, appropriate surgical skills, 49 
translational biomedical knowledge and high experimental reproducibility. A gap in 50 
translation seems to be the main limitation of this process. Rigorous in-vivo validation in 51 
relevant preclinical models may represent an effective way to bridge the gap between 52 
bench-based science and bed side across the storm. Like a bridge over troubled waters. 53 
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